Company: PSTV
Filing Date: 2025-08-04
Form Type: DRS
Source: 0000950123-25-006916
Chunk: 30

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-08-04
Form: DRS
Chunk 30
---
| Lincoln Park under the Purchase Agreement is solely at our discretion and is subject to certain conditions, the satisfaction of all of which are outside of Lincoln Park’s control, including                                                       
 the registration statement that includes this prospectus becoming and remaining effective under the Securities Act, and (ii) any Additional Commitment Shares, because such Additional Commitment Shares are only issuable to Lincoln Park if we    
 elect to pay some or all of the $500,000 additional commitment fee, which will only become payable if and when we receive $25.0 million aggregate gross proceeds from sales of common stock to Lincoln Park under the Purchase Agreement, in shares 
 of our common stock. The [●] shares listed as beneficially owned represent shares held by Lincoln Park. Furthermore, under the terms of the Purchase Agreement, issuances and sales of shares of our common stock to Lincoln Park under the         
 Purchase Agreement are subject to certain limitations on the amounts we may sell to Lincoln Park at any time, including the Beneficial Ownership.                                                                                                   |

| (3) | Although the Purchase Agreement provides that we may sell up to $50.0 million (initially $25 million                                                                                                                                                  
 and if the full $25 million is purchased, then immediately and automatically up to an additional $25 million aggregate gross proceeds) of our common stock to Lincoln Park, we are only registering 33,000,000 shares of our common stock for         
 resale under this prospectus. Depending on the price per share at which we sell our common stock to Lincoln Park pursuant to the Purchase Agreement, we may need to sell to Lincoln Park under the Purchase Agreement more shares of our common stock 
 than are offered under this prospectus in order to receive aggregate gross proceeds equal to the full $50.0 million available to us under the Purchase Agreement. If we choose to do so, we must again register for resale under the Securities Act   
 such additional shares. The number of shares ultimately offered for resale by Lincoln Park is dependent upon the number of shares we sell to Lincoln Park under the Purchase Agreement.                                                               |

18

Confidential Treatment Requested by Plus Therapeutics, Inc.

Pursuant to 17 C.F.R. Section 200.83

MARKET PRICE OF OUR COMMON STOCK AND RELATED STOCKHOLDER MATTERS

Market Information

Our common
stock is traded on the Nasdaq Capital Market under the symbol “PSTV”.

Holders

As of July 30, 2025, there were approximately 17 registered holders of our common stock. This number does not include